Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

23. Januar 2020 07:30 ET | Quelle: Otonomy, Inc.

Otonomy Announces Multiple Presentations at Association for Research in Otolaryngology Annual Meeting

SAN DIEGO, Jan. 23, 2020 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced...
17. September 2019 07:30 ET | Quelle: Otonomy, Inc.

Otonomy Initiating Phase 1/2 Clinical Trial of OTO-413 in Hearing Loss

SAN DIEGO, Sept. 17, 2019 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced the...
25. Februar 2019 16:05 ET | Quelle: Otonomy, Inc.

Otonomy to Report Fourth Quarter and Full Year 2018 Financial Results and Provide Corporate Update

SAN DIEGO, Feb. 25, 2019 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced it...
07. Oktober 2016 08:00 ET | Quelle: Otonomy, Inc.

Otonomy Holds Investor and Analyst Day and Provides Corporate Update

SAN DIEGO, Oct. 07, 2016 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and...
10. November 2015 16:21 ET | Quelle: Otonomy, Inc.

Otonomy Reports Third Quarter 2015 Financial Results and Provides Corporate Update

SAN DIEGO, Nov. 10, 2015 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ:OTIC), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics for...
01. April 2015 07:00 ET | Quelle: Otonomy, Inc.

Otonomy Appoints Dean Hakanson, M.D., as Chief Medical Officer

SAN DIEGO, April 1, 2015 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq:OTIC), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics for...
26. Februar 2015 07:30 ET | Quelle: Otonomy, Inc.

Otonomy Submits New Drug Application to the FDA for AuriPro(TM)

SAN DIEGO, Feb. 26, 2015 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq:OTIC), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics for...
06. Januar 2015 08:00 ET | Quelle: Otonomy, Inc.

Otonomy to Present at the J.P. Morgan Healthcare Conference

SAN DIEGO, Jan. 6, 2015 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq:OTIC), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics for...
01. Oktober 2014 08:00 ET | Quelle: Otonomy, Inc.

Otonomy Added To Russell 2000(R) Index

SAN DIEGO, Oct. 1, 2014 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq:OTIC), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics for...